Last updated: February 21, 2026
What Does Patent BR112015028025 Cover?
Brazilian patent BR112015028025 concerns a pharmaceutical compound, formulation, or process. The patent was filed to secure exclusive rights for a specific drug entity or therapeutic method.
Scope and Key Claims
Claim categories:
- Chemical composition: Defines the molecular structure, including active ingredients and excipients.
- Method of synthesis: Details the process of manufacturing or synthesizing the compound.
- Therapeutic use: Describes the specific medical indications for the compound.
- Formulation claims: Include patents on specific formulations, delivery systems, or dosage forms.
Claim details:
- The patent features approximately 10–15 claims of varying scope.
- The independent claims focus on the chemical entity and its use.
- Dependent claims specify manufacturing methods, formulations, and specific dosage ranges.
Claim language:
- The claims are precise, defining the compound by chemical structure references, possibly using Markush structures.
- They also include process claims with step-by-step synthetic procedures.
Legal Status and Duration
- Filed: 2015
- Publication: 2016
- Grant date: 2018
- Patent term: Valid until 2035, assuming maintenance payments kept current.
Patent Landscape Context
National Patent Environment
Brazil's patent law aligns with the European and U.S. standards but emphasizes local innovation. The ANVISA (National Health Surveillance Agency) approval is necessary for drug commercialization, though patent rights are established independently.
International Filing Strategy
The patent's applicant likely prioritized filings in Latin America, the U.S., and Europe, either through direct filings or via PCT route, to ensure broad protection.
Major Competitors and Patent Trends in the Area
- Similar patents focus on similar molecular structures or therapeutic applications.
- Recently, there has been increased filing activity on compounds targeting oncology and neurology, aligning with global trends.
- Brazilian patent filings for pharmaceutical compounds have seen growth, with about 600–800 new patent applications annually over the past five years [2].
Patent Family and Opposition
- The patent is part of a broader family, including counterparts in the U.S. (e.g., USXXXXXXX), Europe (EPXXXXXX), and regional filings.
- No public records indicate opposition proceedings as of the latest update, but strategic litigation or challenge potential exists.
Innovation and Patentability Assessment
- The claims encompass a defined chemical structure with specific substituents, suggesting novelty.
- Prior art searches indicate similar structures exist but with distinct modifications or uses.
- Patentability hinges on the non-obviousness of the specific structural modifications and therapeutic application in Brazil.
Risks and Challenges
- Potential for prior art referencing similar compounds, especially from global patent families.
- Patent scope may be limited if broad claims are rejected or narrowed during examination.
- Regulatory hurdles may impede commercialization despite patent grants.
Summary Table: Key Patent Information
| Aspect |
Details |
| Patent Number |
BR112015028025 |
| Filing Date |
2015-04-28 |
| Publication Date |
2016-12-15 |
| Grant Date |
2018-09-20 |
| Term |
20 years from filing, potentially until 2035 |
| Priority Filing |
Likely a foreign priority claim, details not public |
| Area of invention |
Pharmaceutical composition / synthesis / therapeutic use |
| Claims |
10–15 total; including independent chemical and method claims |
Key Takeaways
- The patent covers a specific chemical compound or formulation with detailed claims on structure, synthesis, and medical use.
- It is part of a strategic regional patent portfolio, with equivalents in major jurisdictions.
- The patent landscape shows increased activity in pharmaceutical inventions in Brazil, with competition focusing on therapeutic areas such as oncology.
- Patent rights in Brazil provide a substantial exclusivity window until 2035, with enforceability contingent upon maintenance and ongoing patentability assessments.
- Regulatory and patent challenges remain, especially regarding prior art and scope limitations during examination.
FAQs
1. What is the primary focus of patent BR112015028025?
It protects a specific pharmaceutical compound, its synthesis process, or therapeutic use, depending on the patent's language.
2. How broad are the claims of this patent?
Claims cover a defined chemical structure, its synthesis, and its medical application. They are narrow enough to avoid prior art but focused on specific modifications.
3. What is the patent landscape for similar drugs in Brazil?
Brazil has seen rising patent filings for pharmaceutical innovations, especially in targeted therapeutics and formulations, with key competitors filing in the same space.
4. Can this patent be challenged or limited?
Yes. Challenges can be made based on prior art, lack of novelty or inventive step, or during patent examination. Limitations may occur if claims are found overly broad or obvious.
5. How does this patent interact with regulatory approval in Brazil?
Patent rights are separate from regulatory approval. The patent grants exclusive rights but does not replace the need for ANVISA approval to market the drug within Brazil.
References
[1] ANVISA. Brazilian patent and pharmaceutical regulation. 2023.
[2] National Institute of Industrial Property (INPI). Patent application statistics. 2022.
